Stock Chart
MAZE
Type: SELL wallstreet
Strike: $40
Premium: $6.60
Expiry: May 15, 2026
Target: $40
Score: -98
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About MAZE - Maze Therapeutics, Inc. Common Stock
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant …
Key Statistics
More MAZE Analysis
This MAZE stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MAZE's price movements with trendlines, gamma walls, and key support/resistance levels.